Heart Failure: Advances in Medications and Technology

ACPE UAN #:   0233-0000-20-052-H01-P

Release Date: December 7, 2020

Expiration Date:  December 7, 2021

Activity Type:    Knowledge-based

Contact Hours: 1.0 

Activity Fee:  Member:  FREE    Non-Member:  FREE

Target Audience

This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.

Program Description

Heart failure (HF) is one of the costliest diseases in the United States. Due to treatment advances and an aging population, the prevalence of Americans living with HF is increasing, leading to increased health care costs. Acute heart failure syndrome is one of the main contributors to the high cost of HF management, as it often leads to hospitalizations and rehospitalizations. Technology and medications that reduce hospitalizations are of special interest to potentially reduce overall costs.

This session will look at the heart failure treatment pipeline, including pharmacologic and technological advances, as well as the current evidence for reducing hospitalizations, morbidity, and mortality associated with heart failure.

Learning Objectives

At the completion of this activity, participants should be able to:

1. Identify novel component(s) of heart failure (HF) therapies in the FDA pipeline.
2. Examine new technology that can aid in the management of HF.
3. Summarize evidence of HF interventions shown to reduce hospitalizations, morbidity, and mortality.

Statement of Commercial Support 

This educational activity is supported by an unrestricted educational grant from Merck & Co., Inc. and Novartis Pharmaceuticals Corporation.

Accreditation Statement:

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  AMCP intends that all CPE activities be independent, objective, balanced, evidence-based, and free of any commercial bias.

CPE Requirements:   

Participants should claim CPE credit for this home study activity only if they have not claimed credit for the live webinar activity presented on December 7, 2020.

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your National Association of Boards of Pharmacy (NABP) e-Profile account.

To receive credit for a home study activity you must:

  • Review the full content of the home study activity.
  • Complete the post-test and achieve a score of 70% or higher.
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements

Courses and continuing education activities are delivered via your Web browser and Acrobat PDF.  For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for all continuing education activities. 

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-20-052-H01-P 1 Contact Hour December 07, 2020 - December 07, 2021